BRIEF-Hansa Medical: preclinical results confirm IdeS potential in cancer immunotherapy

HANSA MEDICAL AB

* PUBLISHED PRECLINICAL RESULTS CONFIRM IDES POTENTIAL IN CANCER IMMUNOTHERAPY

* PUBLISHED PRECLINICAL RESULTS CONFIRM IDES POTENTIAL IN CANCER IMMUNOTHERAPY

* PUBLISHED FINDINGS DEMONSTRATE HOW PRE-TREATMENT WITH IDES IN TUMOUR ANIMAL MODELS CAN INCREASE EFFICACY OF CURRENTLY AVAILABLE ANTIBODY BASED CANCER THERAPIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

News Source: http://in.reuters.com/article/brief-hansa-medical-preclinical-results-idINFWN1IP05L

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s